Focal adhesion kinase as a potential target in oncology

Expert Opinion on Pharmacotherapy

Volumn 4, Issue 2, 2003, Pages 227-234

  McLean, Gordon W ^a   Avizienyte, Egle ^a   Frame, Margaret C ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Cancer; Cell adhesion; Cell migration; Focal adhesion kinase; Kinase inhibitors; Protein protein interactions

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; FOCAL ADHESION KINASE; IMATINIB; INTEGRIN; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN TYROSINE KINASE; UCS 15A; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CARCINOGENESIS; CELL ADHESION; CELL ANCHORAGE; CELL CONTACT; CELL SURVIVAL; DRUG TARGETING; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; ENZYME INHIBITORS; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 0037327445     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.4.2.227     Document Type: Review

References (74)

1. ULLRICH A, COUSSENS L, HAYFLICK JS, DULL TJ, GREY A, TAM AW et al.: Human epidermal growth factor receptor cDNA Sequence and aberrant expression of the amplified gene in A432 epidermoid carcinoma cells. Nature (1984) 309:418-425.
2. HANKS SK, POLTE TR: Signalling through focal adhesion kinase. Bioessays (1997) 19:137-145.
3. RICHARDSON A, PARSONS JT: Signal transduction through integrins: a central role for focal adhesion kinase? Bioessays (1995) 17:229-236.
4. SCHALLER MD, PARSONS JT: Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol. (1994) 6:705-710.
5. ANDRE E, BECKER-ANDRE M: Expression of an N-terminally truncated form of human focal adhesion kinase in brain. Biochem. Biophys. Res. Commun. (1993) 190:140-147.
6. GRANT SG, KARL KA, KIEBLER MA, KANDEL ER: Focal adhesion kinase in the brain: novel subcellular localization and specific regulation by Fyn tyrosine kinase in mutant mice. Genes Dev. (1995) 9:1909-1921.
7. HANKS SK, CALALB MB, HARPER MC, PATEL SK: Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc. Natl. Acad. Sci. USA (1992) 89:8487-8491.
8. SCHALLER MD, BORGMAN CA, COBB BS, VINES RR, REYNOLDS AB, PARSONS JT: pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. USA (1992) 89:5192-5196.
9. HAN DC, SHEN TL, GUAN JL: Role of Grb7 targeting to focal contacts and its phosphorylation by focal adhesion kinase in regulation of cell migration. J. Biol. Chem. (2000) 275:28911-28917.
10. IZAGUIRRE G, AGUIRRE L, HU YP et al.: The cytoskeletal/non-muscle isoform of α-actinin is phosphorylated on its actin-binding domain by the focal adhesion kinase. J. Biol. Chem. (2001) 276:28676-28685.
11. ILIC D, DAMSKY CH, YAMAMOTO T: Focal adhesion kinase: at the crossroads of signal transduction. J. Cell Sci. (1997) 110:401-407.
12. CALALB MB, POLTE TR, HANKS SK: Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell. Biol. (1995) 15:954-963.
13. CALALB MB, ZHANG X, POLTE TR, HANKS SK: Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src. Biochem. Biophys. Res. Commun. (1996) 228:662-668.
14. HILDEBRAND JD, TAYLOR JM, PARSONS JT: An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol. Cell. Biol. (1996) 16:3169-3178.
15. CHEN H, GUAN J: Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA (1994) 91:10148-10152.
16. SCHLAEPFER DD, HANKS SK, HUNTER T, VAN DER GEER P: Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature (1994) 372:786-791.
17. SCHALLER MD, OTEY CA, HILDEBRAND JD, PARSONS JT: Focal adhesion kinase and paxillin bind to peptides mimicking β integrin cytoplasmic domains.J. Cell Biol. (1995) 130:1181-1187.
18. 1 integrin subunit are constitutively complexed in HaCaT cells. Exp. Cell Res. (1998) 239:326-331.
19. CHISHTI A, KIM A, MARFATIA S et al.: The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem. Sci. (1998) 23:281-282.
20. GIRAULT JA, LABESSE G, MORNON JP, CALLEBAUT I: The N-termini of FAK and JAKs contain divergent band 4.1 domains. Trends Biochem. Sci. (1999) 24:54-57.
21. CRITCHLEY DR: Focal adhesions - the cytoskeletal connection. Curr. Opin. Cell Biol. (2000) 12:133-139.
22. MANGEAT P, ROY C, MARTIN M: ERM proteins in cell adhesion and membrane dynamics. Trends Cell Biol. (1999) 9:187-192.
23. CAS as a mediator of focal adhesion kinase-promoted cell migration. J. Cell Biol. (1998) 140:211-221.
24. HILDEBRAND JD, SCHALLER MD, PARSONS JT: Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J. Cell Biol. (1993) 123:993-1005.
25. MA A, RICHARDSON A, SCHAEFER EM, PARSONS JT: Serine phosphorylation of focal adhesion kinase in interphase and mitosis: a possible role in modulating binding to p130(Cas). Mol. Biol. Cell (2001) 12:1-12.
26. YAMAKITA Y, TOTSUKAWA G, YAMASHIRO S et al.: Dissociation of FAK/p130(CAS)/c-Src complex during mitosis: role of mitosis-specific serine phosphorylation of FAK. J. Cell Biol. (1999) 144:315-324.
27. TAMURA M, GU J, DANEN EH, TAKINO T, MIYAMOTO S, YAMADA KM: PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. (1999) 274:20693-20703.
28. TAMURA M, GU J, MATSUMOTO K, AOTA S, PARSONS R, YAMADA KM: Inhibition of cell migration, spreading and focal adhesions by tumour suppressor PTEN. Science (1998) 280:1614-1617.
29. SCHALLER MD, BORGMAN CA, PARSONS JT: Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK. Mol. Cell. Biol. (1993) 13:785-791.
30. NOLAN K, LACOSTE J, PARSONS JT: Regulated expression of focal adhesion kinase-related nonkinase, the autonomously expressed C-terminal domain of focal adhesion kinase. Mol. Cell. Biol. (1999) 19:6120-6129.
31. TAYLOR JM, MACK CP, NOLAN K, REGAN CP, OWENS GK, PARSONS JT: Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells. Mol. Cell. Biol. (2001) 21:1565-1572.
32. ILIC D, FURUTA Y, KANAZAWA S, TAKEDA N, SOBUE K, NAKATSUJI N et al.: Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature (1995) 377:539-544.
33. RICHARDSON A, PARSONS T: A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK. Nature (1996) 380:538-540.
34. FINCHAM VJ, FRAME MC: The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility. EMBO J. (1998) 17:81-92.
35. FINCHAM VJ, WYKE JA, FRAME MC: v-Src-induced degradation of focal adhesion kinase during morphological transformation of chicken embryo fibroblasts. Oncogene (1995) 10:2247-2252.
36. MCLEAN GW, FINCHAM VJ, FRAME MC: v-Src induces tyrosine phosphorylation of focal adhesion kinase independently of tyrosine 397 and formation of a complex with Src. J. Biol. Chem. (2000) 275:23333-23339.
37. CARY LA, CHANG JF, GUAN JL: Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J. Cell Sci. (1996) 109:1787-1794.
38. AKASAKA T, VAN LEEUWEN RL, YOSHINAGA IG, MIHM MC Jr, BYERS HR: Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines. J. Invest. Dermatol. (1995) 105:104-108.
39. PARSONS JT, MARTIN KH, SLACK JK, TAYLOR JM, WEED SA: Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene (2000) 19:5606-5613.
40. WANG D, GRAMMER JR, COBBS CS, STEWART JE Jr, LIU Z, RHODEN R, HECKER TP, DING Q, GLADSON CL: p125 focal adhesion kinase promotes malignant astrocytoma cell proliferation in vivo. J. Cell Sci. (2000) 113:4221-4230.
41. AVIZIENYTE E, WYKE AW, JONES RJ, MCLEAN GW, WESTHOFF MA, BRUNTON VG, FRAME MC: Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat. Cell Biol. (2002) 4:632-638.
42. GATES RE, KING LE Jr, HANKS SK, NANNEY LB: Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture. Cell Growth Differ. (1994) 5:891-899.
43. FRISCH SM, VUORI K, RUOSLAHTI E, CHAN-HUI PY: Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. (1996) 134:793-799.
44. CHAN PC, LAI JF, CHENG CH, TANG MJ, CHIU CC, CHEN HC: Suppression of ultraviolet irradiation-induced apoptosis by overexpression of focal adhesion kinase in Madin-Darby canine kidney cells. J. Biol. Chem. (1999) 274:26901-26906.
45. GOLUBOVSKAYA V, BEVIGLIA L, XU LH, EARP HS, CRAVEN R, CANCE W: Dual inhibition of focal adhesion kinase (FAK) and epidermal growth factor receptor (EGFR) pathways cooperatively induces death receptor- mediated apoptosis in human breast cancer cells. J. Biol. Chem. (2002) 277:38978-38987.
46. IRBY RB, MAO W, COPPOLA D et al.: Activating SRC mutation in a subset of advanced human colon cancers. Nat. Genet. (1999) 21:187-190.
47. ROBERTSON SC, TYNAN J, DONOGHUE DJ: RTK mutations and human syndromes: when good receptors turn bad. Trends Genet. (2000) 16:368-369.
48. AGOCHIYA M, BRUNTON VG, OWENS DW et al.: Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene (1999) 18:5646-5653.
49. BRUNTON VG, OZANNE BW, PARASKEVA C, FRAME MC: A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer. Oncogene (1997) 14:283-293.
50. MCCORMACK SJ, BRAZINSKI SE, MOORE JL Jr, WERNESS BA, GOLDSTEIN DJ: Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus Type 18. Oncogene (1997) 15:265-274.
51. TREMBLAY L, HAUCK W, APRIKIAN AG, BEGIN LR, CHAPDELAINE A, CHEVALIER S: Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma. Int. J. Cancer (1996) 68:164-171.
52. OWENS LV, XU L, CRAVEN RJ, DENT GA et al.: Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumours. Cancer Res. (1995) 55:2752-2755.
53. KORNBERG LJ: Focal adhesion kinase expression in oral cancers. Head Neck (1998) 20:634-639.
54. OWENS LV, XU L, DENT GA, YANG X et al.: Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann. Surg. Oncol. (1996) 3:100-105.
55. JUDSON PL, HE X, CANCE WG, VAN LE L: Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer (1999) 86:1551-1556.
56. KORNBERG LJ: Focal adhesion kinase and its potential involvement in tumour invasion and metastasis. Head Neck (1998) 20:745-752.
57. HAUCK CR, SIEG DJ, HSIA DA et al.: Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signalling promoting the migration of invasive human carcinoma cells. Cancer Res. (2001) 61:7079-7090.
58. 1 integrin-containing invadopodia promotes cell invasion. J. Biol. Chem. (2002) 277:12487-12490.
59. HAUCK CR, HSIA DA, PUENTE XS et al.: FRNK blocks v-Src stimulated invasion and experimental metastases without effects on cell motility or growth. EMBO Journal:(In press).
60. HAUCK CR, HSIA DA, SCHLAEPFER DD: The focal adhesion kinase - a regulator of cell migration and invasion. IUBMB Life (2002) 53:115-119.
61. SHIBATA K, KIKKAWA F, NAWA A et al.: Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Res. (1998) 58:900-903.
62. MCLEAN GW, BROWN K, ARBUCKLE MI et al.: Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis. Cancer Res. (2001) 61:8385-8389.
63. 4 integrin ligation to mCLCA1 mediates early metastatic growth. J. Biol. Chem. (2002) 10:10.
64. GOLEMIS EA, OCHS MF, PUGACHEVA EN: Signal transduction driving technology driving signal transduction: factors in the design of targeted therapies. J. Cell. Biochem. Suppl. (2001) Suppl. 37:42-52.
65. SHARMA SV, ONEYAMA C, YAMASHITA Y et al.: UCS15A, a non-kinase inhibitor of Src signal transduction. Oncogene (2001) 20:2068-2079.
66. ONEYAMA C, NAKANO H, SHARMA SV: UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug. Oncogene (2002) 21:2037-2050.
67. SIEG DJ, HAUCK CR, SCHLAEPFER DD: Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration J. Cell Sci. (1999) 112:2677-2691.
68. LU Z, JIANG G, BLUME-JENSENP, HUNTER T: Epidermal growth factor-induced tumour cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol. Cell. Biol. (2001) 21:4016-4031.
69. KAHANA O, MICKSCHE M, WITZ IP, YRON I: The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma. Oncogene (2002) 21:3969-3977.
70. NEWELL SW, PERCHELLET JP, PERCHELLET EM, ULUG ET: Alterations in focal adhesion kinase activity and associated proteins during malignant conversion of mouse keratinocytes. Mol. Carcinog. (1999) 25:73-83.
71. LEVITZKI A: Protein tyrosine kinase inhibitors as novel therapeutic agents. Pharmacol. Ther. (1999) 82:231-239.
72. FRY DW: Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer. Anti-Cancer Drug Des. (2000) 15:3-16.
73. MORIN MJ: From oncogene to drug: development of small molecule tyrosine kinase inhibitors as antitumour and antiangiogenic agents. Oncogene (2000) 19:6574-6583.
74. MUGHAL TI, GOLDMAN JM: Chronic myeloid leukaemia. STI 571 magnifies the therapeutic dilemma. Eur. J. Cancer (2001) 37:561-568.